Keywords: shire, posts, rise, sales, sees, good, prospects
Shire posts 41% rise in 2007 sales; sees good prospects for Vynase
Article | 03 March 2008
Shire, the UK's third-largest pharmaceutical company, has reported a healthy set of fourth-quarter and full-year 2007 results. The news lifted the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
